SCHEMBL12522571

SCHEMBL12522571

CCCCNc1cc(C(O)=S)cc(S)c1Oc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.54
▸ NPSR1 Q6W5P4 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.54
▸ USP2 O75604 1/20 0.54
▸ CA2 P00918 1/20 0.54
▸ LMNA P02545 1/20 0.54
▸ HPGD P15428 1/20 0.54
▸ TSHR P16473 1/20 0.54
▸ BLM P54132 1/20 0.54
▸ SLC12A2 P55011 1/20 0.54
▸ HIF1A Q16665 1/20 0.54
▸ HSD17B10 Q99714 1/20 0.54
▸ AQP1 P29972 1/20 0.46
▸ PTGS2 P35354 12/20 0.45
▸ MAPT P10636 3/20 0.43
▸ HTT P42858 2/20 0.43
▸ GAA P10253 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ HDAC3 O15379 1/20 0.40
▸ POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12522564 0.92 ALDH1A1 (0.53) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL2874561 0.92 ALDH1A1 (0.53) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL12522572 0.91 ALDH1A1 (0.53) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL2881757 0.91 ALDH1A1 (0.53) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL2879559 0.88 KDM4E (0.69) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL2875996 0.87 ALDH1A1 (0.59) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL12522799 0.86 KDM4E (0.58) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL2880748 0.86 HPGD (0.58) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL19300036 0.84 KDM4E (0.59) ALDH1A1NPSR1KDM4EUSP2CA2
SCHEMBL2879535 0.83 LMNA (0.55) ALDH1A1NPSR1KDM4EUSP2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120234721-A1 DIURETIC AND DIURETIC-LIKE COMPOUND ANALOGS NEUROTHERAPEUTICS PHARMA, INC. (US) 2012-09-20 — — US disclosed
US-20090215754-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS NEUROTHERAPEUTICS PHARMA, INC. 2009-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120234721-A1 DIURETIC AND DIURETIC-LIKE COMPOUND ANALOGS AQP4, AVPR2, AQP1 ALDH1A1 687/4885NPSR1 133/4885KDM4E 3557/4885
US-20090215754-A1 METHODS AND COMPOSITIONS FOR THE TREATMENT OF NEUROPSYCHIATRIC AND ADDICTIVE DISORDERS SLC6A2, SLC1A2, SLC18A2 ALDH1A1 701/4885NPSR1 108/4885KDM4E 1504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback